The influence of the assessment method on the incidence of visual field progression in glaucoma: A network meta-analysis

Acta Ophthalmologica

Volumn 90, Issue 1, 2012, Pages 10-19

  Ernest, Paul J G ^a,b   Viechtbauer, Wolfgang ^a   Schouten, Jan S A G ^b   Beckers, Henny J M ^b   Hendrikse, Fred ^b   Prins, Martin H ^a   Webers, Carroll A B ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

disease progression; glaucoma; meta analysis; perimetry

Indexed keywords

DIAGNOSTIC TEST; DISEASE COURSE; FOLLOW UP; GLAUCOMA; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; META ANALYSIS; PERIMETRY; PRIORITY JOURNAL; REFERENCE VALUE; REVIEW; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; VARIANCE; VISUAL FIELD DEFECT; VISUAL SYSTEM EXAMINATION; VISUAL SYSTEM PARAMETERS;

AGED; DISEASE PROGRESSION; GLAUCOMA, OPEN-ANGLE; HUMANS; INCIDENCE; MIDDLE AGED; VISION DISORDERS; VISUAL FIELD TESTS; VISUAL FIELDS;

EID: 84856557196     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2010.01995.x     Document Type: Review

References (37)

1. Arnalich Montiel F, Casas Llera P, Munoz Negrete FJ, &, Rebolleda G, (2009): Performance of glaucoma progression analysis software in a glaucoma population. Graefes Arch Clin Exp Ophthalmol 247: 391-397.
2. Artes PH, Nicolela MT, LeBlanc RP, &, Chauhan BC, (2005): Visual field progression in glaucoma: total versus pattern deviation analyses. Invest Ophthalmol Vis Sci 46: 4600-4606. (Pubitemid 44264560)
3. Bengtsson B, &, Heijl A, (2008): A visual field index for calculation of glaucoma rate of progression. Am J Ophthalmol 145: 343-353.
4. Bengtsson B, Patella VM, &, Heijl A, (2009): Prediction of glaucomatous visual field loss by extrapolation of linear trends. Arch Ophthalmol 127: 1610-1615.
5. Birch MK, Wishart PK, &, O'Donnell NP, (1995): Determining progressive visual field loss in serial Humphrey visual fields. Ophthalmology 102: 1227-1234; discussion 1234-1225.
6. Boden C, Blumenthal EZ, Pascual J, McEwan G, Weinreb RN, Medeiros F, &, Sample PA, (2004): Patterns of glaucomatous visual field progression identified by three progression criteria. Am J Ophthalmol 138: 1029-1036. (Pubitemid 40040020)
7. Bucher HC, Guyatt GH, Griffith LE, &, Walter SD, (1997): The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol 50: 683-691. (Pubitemid 27341818)
8. Caldwell DM, Ades AE, &, Higgins JP, (2005): Simultaneous comparison of multiple treatments: combining direct and indirect evidence. BMJ 331: 897-900. (Pubitemid 41502718)
9. Caprioli J, (2008): The importance of rates in glaucoma. Am J Ophthalmol 145: 191-192.
10. Casas Llera P, Rebolleda G, Munoz Negrete FJ, Arnalich Montiel F, Perez Lopez M, &, Fernandez Buenaga R, (2009): Visual field index rate and event-based glaucoma progression analysis: comparison in a glaucoma population. Br J Ophthalmol 93: 1576-1579.
11. Chauhan BC, Mikelberg FS, Balaszi AG, LeBlanc RP, Lesk MR, &, Trope GE, (2008): Canadian Glaucoma Study: 2. risk factors for the progression of open-angle glaucoma. Arch Ophthalmol 126: 1030-1036.
12. Diaz Aleman VT, Anton A, de la Rosa MG, Johnson ZK, McLeod S, &, Azuara Blanco A, (2009): Detection of visual-field deterioration by Glaucoma Progression Analysis and Threshold Noiseless Trend programs. Br J Ophthalmol 93: 322-328.
13. Gonzalez De La Rosa M, Gonzalez Hernandez M, &, Diaz Aleman T, (2009): Linear regression analysis of the cumulative defect curve by sectors and other criteria of glaucomatous visual field progression. Eur J Ophthalmol 19: 416-424.
14. Hardy RJ, &, Thompson SG, (1996): A likelihood approach to meta-analysis with random effects. Stat Med 15: 619-629. (Pubitemid 26109009)
15. Heijl A, Lindgren G, &, Olsson J, (1987): A package for the statistical analysis of visual fields. In: Doc Ophthalmol Proc Ser. Dordrecht: Martinus Nijhoff Publishers 153-168.
16. Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, &, Hussein M, (2002): Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 120: 1268-1279. (Pubitemid 36105431)
17. Heijl A, Bengtsson B, Chauhan BC, Lieberman MF, Cunliffe I, Hyman L, &, Leske MC, (2008): A comparison of visual field progression criteria of 3 major glaucoma trials in early manifest glaucoma trial patients. Ophthalmology 115: 1557-1565.
18. Katz J, (1999): Scoring systems for measuring progression of visual field loss in clinical trials of glaucoma treatment. Ophthalmology 106: 391-395. (Pubitemid 30191643)
19. Katz J, (2000): A comparison of the pattern- and total deviation-based Glaucoma Change Probability programs. Invest Ophthalmol Vis Sci 41: 1012-1016. (Pubitemid 30187535)
20. Katz J, Gilbert D, Quigley HA, &, Sommer A, (1997): Estimating progression of visual field loss in glaucoma. Ophthalmology 104: 1017-1025. (Pubitemid 27255415)
21. Katz J, Congdon N, &, Friedman DS, (1999): Methodological variations in estimating apparent progressive visual field loss in clinical trials of glaucoma treatment. Arch Ophthalmol 117: 1137-1142. (Pubitemid 29428821)
22. Lee AC, Sample PA, Blumenthal EZ, Berry C, Zangwill L, &, Weinreb RN, (2002): Infrequent confirmation of visual field progression. Ophthalmology 109: 1059-1065. (Pubitemid 34546911)
23. Leske MC, Heijl A, Hyman L, &, Bengtsson B, (1999): Early Manifest Glaucoma Trial: design and baseline data. Ophthalmology 106: 2144-2153. (Pubitemid 30194238)
24. Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L, &, Yang Z, (2007): Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology ISE: 1549 4713 114: 1965-1972. (Pubitemid 350016362)
25. Lichter PR, Musch DC, Gillespie BW, Guire KE, Janz NK, Wren PA, &, Mills M, (2001): Interim clinical outcomes in the collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgery. Ophthalmology 108: 1943-1953. (Pubitemid 33032760)
26. Mayama C, Araie M, Suzuki Y, et al., (2004): Statistical evaluation of the diagnostic accuracy of methods used to determine the progression of visual field defects in glaucoma. Ophthalmology 111: 2117-2125. (Pubitemid 39446733)
27. Nouri Mahdavi K, Hoffman D, Ralli M, &, Caprioli J, (2007): Comparison of methods to predict visual field progression in glaucoma. Arch Ophthalmol 125: 1176-1181. (Pubitemid 47403022)
28. Polansky JR, Juster RP, &, Spaeth GL, (2003): Association of the myocilin mt.1 promoter variant with the worsening of glaucomatous disease over time. Clin Genet 64: 18-27. (Pubitemid 36949945)
29. Riley RD, Thompson JR, &, Abrams KR, (2008): An alternative model for bivariate random-effects meta-analysis when the within-study correlations are unknown. Biostatistics 9: 172-186. (Pubitemid 350274590)
30. Salanti G, Higgins JP, Ades AE, &, Ioannidis JP, (2008): Evaluation of networks of randomized trials. Stat Methods Med Res 17: 279-301.
31. Schulzer M, Anderson DR, &, Drance SM, (1991): Sensitivity and specificity of a diagnostic test determined by repeated observations in the absence of an external standard. J Clin Epidemiol 44: 1167-1179.
32. Smith SD, Katz J, &, Quigley HA, (1996): Analysis of progressive change in automated visual fields in glaucoma. Invest Ophthalmol Vis Sci 37: 1419-1428. (Pubitemid 26177317)
33. Spry PGD, &, Johnson CA, (2002): Identification of progressive glaucomatous visual field loss. Surv Ophthalmol 47: 158-173. (Pubitemid 34256411)
34. The AGIS Investigators (1994): Advanced Glaucoma Intervention Study. 2. Visual field test scoring and reliability. Ophthalmology 101: 1445-1455.
35. The AGIS Investigators (2000): The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 130: 429-440.
36. Viswanathan AC, Crabb DP, McNaught AI, Westcott MC, Kamal D, Garway Heath DF, Fitzke FW, &, Hitchings RA, (2003): Interobserver agreement on visual field progression in glaucoma: a comparison of methods. Br J Ophthalmol 87: 726-730. (Pubitemid 36649225)
37. Wesselink C, Heeg GP, &, Jansonius NM, (2009): Glaucoma monitoring in a clinical setting: glaucoma progression analysis vs nonparametric progression analysis in the Groningen longitudinal glaucoma study. Arch Ophthalmol 127: 270-274.